Current Weight Loss Medications: What Plastic Surgeons Should Know.
Abstract
The World Health Organization (WHO) estimates that over 650 million adults are obese worldwide. Recently, antidiabetic medications have rapidly become popular as weight loss medications. With the rising prevalence of obesity and the increasing demand for aesthetic procedures, it is anticipated that a growing number of patients presenting for consultation will be prescribed these medications. Therefore, it is critical for practicing plastic surgeons to understand their potential synergistic effects and safety considerations. This manuscript explores the potential benefits and considerations of antidiabetic medications in plastic surgery patients for weight loss therapy. The authors discuss the mechanisms of action, clinical efficacy, potential side effects, and relevant considerations for incorporating these medications into plastic surgery practices and medical spas.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | Weight Loss
|
C1262477
Weight Loss
|
scispacy | 1 | |
| 질환 | obesity
|
C0028754
Obesity
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Adult; Humans; Surgery, Plastic; Plastic Surgery Procedures; Obesity; Surgeons; Weight Loss; Hypoglycemic Agents